"future placement of tooth implants if needed will be much easier," he said..eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. super bowl festivities capped by an eagles win in minnesota.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..
.